BridgeBio Pharma, Inc.

NASDAQ:BBIO

28.12 (USD) • At close January 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 266.324407.958475.353375.935505.213302.438407.368376.689483.235470.098371.55393.772180.347378.42471.176356.082366.967540.919757.049363.773413.973293.803373.027436.086-91.995
Short Term Investments 039.81344.46958.94938.052333.30734.12295.233108.742245.607299.676442.891419.264459.243447.942251.011343.714300.02148.126182.22122.08000183.99
Cash and Short Term Investments 266.324447.771519.822434.884505.213333.307441.49428.269591.977715.705671.226787.515599.611898.351919.118607.093710.681840.939928.385577.137536.053293.803373.027436.08691.995
Net Receivables 0.4780.66235.4941.7515.178.61410.76117.07924.58122.82110.98319.7498.1721.2130.46208002.84500000
Inventory 00016.65316.65219.9325.50337.93000001.21300000-2.84500000
Other Current Assets 177.776167.80528.23940.95839.23540.47650.64859.85225.52132.61433.84432.44631.92770.99525.53471.32326.70341.99239.56442.41322.10212.9069.4469.1370
Total Current Assets 444.578616.236783.424477.593549.618382.397502.899505.2642.219771.28716.23839.71639.71970.559945.114642.824745.384861.935948.167599.766558.155306.709382.473445.22391.995
Non-Current Assets:
Property, Plant & Equipment, Net 15.1417.10719.46619.84321.74522.86124.09825.24727.34129.72331.11845.97344.84942.23635.81336.83325.82626.03824.615.6252.9841.8651.8821.5750
Goodwill 0000000000000000000000000
Intangible Assets 025.12325.72126.31926.91727.51528.11328.71229.3129.90830.47644.93446.204000000000000
Goodwill and Intangible Assets 24.52525.12325.72126.31926.91727.51528.11328.71229.3129.90830.47644.93446.204000000000000
Long Term Investments 160.443119.1483.9433.74438.05250.48749.80343.65311.612.4082.46649.14817.70718.89482.20200023.2131.14476.7937.49512.45217.050
Tax Assets 0-119.148-0-3.7440000-11.61-2.408-2.46600000000000000
Other Non-Current Assets 20.29116.76116.77922.62518.67620.40120.76720.22429.8731.32232.85933.02733.05449.79730.17923.93116.48317.254-6.188-4.8562.5989.4714.5671.093-91.995
Total Non-Current Assets 220.399178.13965.90968.787105.39121.264122.781117.83686.52190.95396.919173.082141.814110.927148.19460.76442.30943.29241.63231.91382.37518.83118.90119.718-91.995
Total Assets 664.977794.375849.333546.38655.008503.661625.68623.036728.74862.233813.1491,012.792781.5241,081.4861,093.308703.588787.693905.227989.799631.679640.53325.54401.374464.9410
Liabilities & Equity:
Current Liabilities:
Account Payables 13.36318.1264.72810.6554.4723.8744.07611.55810.1588.79310.10711.88412.03522.32910.348.9459.83912.83513.0868.85210.2716.06512.34413.5090
Short Term Debt 4.69.2469.0888.2564.1377.5527.3483.6754.0448.628.7264.9385.2824.5411.265.2537.2347.2545.02000000
Tax Payables 0000000000000000000000000
Deferred Revenue 11.77115.09813.9576.0966.5926.216.6758.1567.5187.19000-4.54075.957.05370.90243.26931.45500000
Other Current Liabilities 109.48291.894113.704118.83790.86492.48478.49798.03997.474116.55784.63118.24778.506105.0473.12981.4558.63472.55146.80851.53329.58822.6423.12819.0680
Total Current Liabilities 139.216134.364141.477143.844101.928106.34492.922117.753119.194141.16103.463130.13195.823127.36994.72991.85375.70792.6462.40452.38539.85838.70535.47232.5770
Non-Current Liabilities:
Long Term Debt 1,725.1491,724.6581,724.2291,735.711,730.8931,729.8531,725.1961,719.8891,711.6931,707.4551,723.5441,721.2331,395.3261,393.3491,375.061490.534480.13475.676470.01791.79175.01774.99754.86154.5070
Deferred Revenue Non-Current 18.62716.96119.89000009.20000000000000000
Deferred Tax Liabilities Non-Current 008.29700000-9.20000000000000000
Other Non-Current Liabilities 0.3770.4850.5959.36111.78513.32617.50126.64328.22628.63126.82922.06926.24911.85311.6129.5213.4699.3992.7973.5271.388479.3910.38479.360
Total Non-Current Liabilities 1,744.1531,742.1041,744.7141,745.0711,746.8151,746.9551,746.3711,750.2071,739.9191,736.0861,750.3731,748.241,421.5751,409.7421,386.673503.849493.599485.075475.324103.31876.405554.38855.241533.8670
Total Liabilities 1,883.3691,876.4681,886.1911,888.9151,848.7431,853.2991,839.2931,867.961,859.1131,877.2461,853.8361,878.3711,517.3981,537.1111,481.402595.702569.306577.715537.728155.703116.263593.09390.713566.4440
Equity:
Preferred Stock 00000000000000000002.24300.175479.0440.122143.867
Common Stock 0.1950.1940.1930.1810.180.1680.1670.1570.1560.1540.1540.1540.1530.1530.1520.1250.1250.1250.1240.1240.1179.9490.16.5940
Retained Earnings -2,831.213-2,669.173-2,595.717-2,560.501-2,392.353-2,215.354-2,057.455-1,918.149-1,780.558-1,643.219-1,633.363-1,436.966-1,289.789-1,133.854-1,037.506-888.755-768.774-652.915-531.881-440.031-366.573-326.068-234.733-170.580
Accumulated Other Comprehensive Income/Loss 0.005-0.0040.0020.0310.0340.063-0.012-0.328-0.348-0.427-0.383-0.1320.0190.036-0.0570.1920.4610.8580.7260.2540.1520-479.044-0.231-61.427
Other Total Stockholders Equity 1,601.0911,576.0581,545.9941,206.0321,184.596853.1831.635663.703642.333617.96592.596566.53546.22669.371642.117946.344931.944917.691911.746848.107826.0629.9497.7315.3663.331
Total Shareholders Equity -1,229.922-1,092.925-1,049.528-1,354.257-1,207.543-1,362.023-1,225.665-1,254.617-1,138.417-1,025.532-1,040.996-870.414-743.397-464.294-395.29457.906163.756265.759380.715408.454459.758-316.119252.141-163.98685.771
Total Equity -1,218.392-1,082.093-1,036.858-1,342.535-1,193.735-1,349.638-1,213.613-1,244.924-1,130.373-1,015.013-1,040.687-865.579-735.874-455.625-388.094107.886218.387327.512452.071475.976524.267-267.553310.661-101.50385.771
Total Liabilities & Shareholders Equity 664.977794.375849.333546.38655.008503.661625.68623.036728.74862.233813.1491,012.792781.5241,081.4861,093.308703.588787.693905.227989.799631.679640.53325.54401.374464.94185.771